Assenagon Asset Management S.A. Takes $193,000 Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)
Assenagon Asset Management S.A. purchased a new position in shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) in the first quarter, HoldingsChannel.com reports. The firm purchased 293,949 shares of the biopharmaceutical company’s stock, valued at approximately $193,000. Several other hedge funds and other institutional investors also recently bought and sold shares of the business. […]
Assenagon Asset Management S.A. purchased a new position in shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) in the first quarter, HoldingsChannel.com reports. The firm purchased 293,949 shares of the biopharmaceutical company’s stock, valued at approximately $193,000. Several other hedge funds and other institutional investors also recently bought and sold shares of the business. […]
